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Introduction
The presence of metabolic syndrome is associated
with increased long-term risk for both atherosclerotic
cardiovascular disease (CVD) and type 2 diabetes
mellitus, and should thus be addressed in clinical
practice (1,2). The National Cholesterol Education
Program (NCEP) Adult Treatment Panel III (ATP
III) report deﬁned metabolic syndrome as the follow-
ing constellation of risk factors: dyslipidaemia, hyper-
tension and insulin resistance, abdominal obesity, as
well as an inﬂammatory and prothrombotic state (2),
with each metabolic syndrome component associated
with heightened cardiovascular risk (1,3). ATP III,
the National Heart, Lung and Blood Institute, and
the American Heart Association have identiﬁed spe-
ciﬁc underlying risk factors for metabolic syndrome,
including obesity, physical inactivity, atherogenic
diet, cigarette smoking, and family history of prema-
ture coronary heart disease (2,3). However, other
well-deﬁned factors beyond the clinical criteria that
deﬁne metabolic syndrome, such as patient knowl-
edge, attitudes and behaviour, may contribute to the
development of metabolic syndrome as well as to the
diseases to which it predisposes.
Because its components are readily measurable in
clinical practice, metabolic syndrome provides an
opportunity for clinicians to assess risk during a
standard ofﬁce visit. However, identifying metabolic
syndrome is just the ﬁrst step. Preventing CVD
requires that patients possess adequate knowledge
and awareness of the syndrome’s diagnostic criteria,
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SUMMARY
Purpose: This study assessed awareness of metabolic syndrome and evaluated
health knowledge, attitudes and behaviours of respondents at risk. Methods:
Study to Help Improve Early evaluation and management of risk factors Leading to
Diabetes (SHIELD), a longitudinal US population-based survey initiated in 2004,
included respondents, ‡ 18 years of age, reporting a diagnosis of metabolic syn-
drome. Prevalence of metabolic syndrome was compared in SHIELD and National
Health and Nutrition Examination Survey (NHANES) 1999–2002 survey. The pro-
portion of SHIELD respondents who had heard of and⁄or understood metabolic
syndrome was estimated. Respondents at high risk for metabolic syndrome were
stratiﬁed into attitude-behaviour categories of ‘Already Doing It’, ‘I Know I Should’
and ‘Don’t Bother Me’ and differences in attitudes and behaviours were evaluated
with chi-square tests. Results: Prevalence of reported metabolic syndrome was
0.6% in SHIELD screening questionnaire respondents (n = 211,097) vs. 25.9% in
NHANES (n = 10,780). Less than 15% of SHIELD baseline questionnaire respon-
dents (n = 22,001) had heard of or understood metabolic syndrome. Attitudes
toward health status were more favourable in the ‘Doing’ group (27% reported
fair⁄poor health) compared with those in the ‘Should’ (38%) and ‘Don’t’ (54%)
groups (p < 0.0001). The ‘Don’t’ group was most likely to prefer medications to
lifestyle change (13% vs. 2–4%) compared with ‘Should’ and ‘Doing’ groups
(p < 0.0001). More ‘Doing’ respondents (79%) than ‘Should’ (59%) and ‘Don’t’
(48%) respondents reported exercising regularly (p < 0.0001). Conclusions: The
lack of knowledge about metabolic syndrome reported in SHIELD indicates limited
penetration of this concept into public awareness. With behaviour categories,
respondents who report healthy attitudes are more likely to embrace lifestyle
changes, while respondents who do not care may be more difﬁcult to treat.
What’s known
Metabolic syndrome, a constellation of
cardiometabolic risk factors, is associated with
increased risk for cardiovascular disease (CVD) and
diabetes mellitus. Interventions to prevent or
manage dyslipidaemia, hypertension, insulin
resistance and abdominal obesity have been shown
to reduce the CVD risk.
What’s new
Patient knowledge, attitudes and behaviour play a
large role in preventing and managing the risk
factors comprising metabolic syndrome. The present
study provides insight into the health-related
attitudes and behaviours of respondents with or at
risk for metabolic syndrome, including awareness
and understanding of the syndrome. Improved
understanding of self-reported attitudes and
behaviours may facilitate more effective
communication with physicians and intervention
strategies for patients at risk for diabetes and
cardiovascular disease.
Linked Comment: Wierzbicki. Int J Clin Pract 2008; 62: 1132–4.
doi: 10.1111/j.1742-1241.2008.01770.x
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behaviours required to reduce such risk. The
conundrum, however, is that while patients may be
aware that they have the conditions that compose
metabolic syndrome, they may not understand that
these conditions put them at high risk for CVD and
diabetes. Furthermore, the transition from under-
standing risk to moderating it is hampered by
patient-speciﬁc barriers that must also be identiﬁed
and managed. Patient education alone often does not
result in health-enhancing behaviour change, as risk
reduction typically requires sustained lifestyle modiﬁ-
cations.
The Study to Help Improve Early evaluation and
management of risk factors Leading to Diabetes
(SHIELD) is a large, longitudinal US population-
based survey that provides a unique opportunity to
gain further insight into the health-related attitudes
and behaviours of respondents with or at risk for
metabolic syndrome. The objectives of this investiga-
tion were to determine whether individuals were
aware of and understood metabolic syndrome and to
evaluate knowledge, attitudes and behaviours among
those at high risk of metabolic syndrome. It is hoped
that improved understanding of these attitudes and
behaviours will facilitate more effective clinically
based communication and intervention strategies for
patients at risk for diabetes and CVD.
Methods
SHIELD questionnaire
A screening questionnaire was mailed in April 2004
to a stratiﬁed random sample of 200,000 US house-
holds, representative of the US population for age of
head of household, income, household size, urban
density and census region, identiﬁed by the Taylor
Nelson Sofres (TNS) National Family Opinion panel
(Greenwich, CT). The screening questionnaire con-
sisted of 12 questions designed to identify individuals
with diabetes and those with risk factors for diabetes.
A response rate of 64% (n=211,097 adults
‡ 18 years of age) was achieved. A detailed baseline
questionnaire was then mailed in September 2004 to
22,001 screened individuals who were identiﬁed with
diabetes or risk factors related to diabetes. The base-
line questionnaire assessed comorbid conditions,
health status, knowledge, attitudes, current
behaviours related to general health and diabetes,
exercise, diet and weight loss. A response rate of
80% was achieved. A detailed description of the
SHIELD methodology has been published elsewhere
(4,5).
Respondents were classiﬁed according to diagnosis
of diabetes (type 1 or type 2) and risk factors associ-
ated with increased risk of type 2 diabetes. Recogni-
sed cardiometabolic risk factors, derived from the
literature, national guidelines and expert opinion
(2,6), included: (i) abdominal obesity (deﬁned as
waist circumference ‡ 97 cm for men and ‡ 89 cm
for women), (ii) body mass index (BMI)
‡ 28 kg⁄m
2, (iii) diagnosis of dyslipidaemia (choles-
terol problems), (iv) diagnosis of hypertension (high
blood pressure) and (v) diagnosis of CVD (deﬁned
as one or more of heart disease, myocardial infarc-
tion, narrow or blocked arteries, stroke, coronary
artery bypass graft surgery, angioplasty, stents or sur-
gery to clear arteries). Stepwise logistic regression
analyses veriﬁed that these ﬁve cardiometabolic risk
factors were independently and equally predictive of
diabetes diagnosis. Respondents with zero, one or
two of the ﬁve risk factors were further classiﬁed as
low risk for diabetes, and respondents with 3–5 risk
factors were classiﬁed as high risk.
For metabolic syndrome, SHIELD respondents
were asked if they had ever been told by a doctor,
nurse or other health professional that they had met-
abolic syndrome or syndrome X. The proportion of
respondents reporting a diagnosis of metabolic syn-
drome was estimated as the prevalence of metabolic
syndrome in SHIELD. Previous panel surveys have
been used to calculate the population prevalence of
conditions such as migraine (7) and bipolar disorder
(8).
Assessing knowledge, attitudes and behaviours
Knowledge, attitudes and behaviours of respondents
in the high-risk group were evaluated in the context
of a system used by the American Dietetic Associa-
tion (ADA) (9). SHIELD respondents with 3–5 car-
diometabolic risk factors (high risk) were assigned to
one of the following three groups derived from
ADA-deﬁned behaviour categories:
• ‘Already Doing It’ (Doing), consisting of people
who are concerned about diet, nutrition and ﬁtness,
and have taken signiﬁcant actions to change their
eating patterns and lifestyles in accordance with these
concerns.
• ‘I Know I Should, but…’ (Should), consisting of
people who are concerned about the above issues,
but have not taken signiﬁcant actions to address
their concerns.
• ‘Don’t Bother Me’ (Don’t), consisting of people
who are not concerned about their diet, overall
nutrition and ﬁtness.
Respondents were assigned to one of these groups
based on their response to an attitude question in
the SHIELD baseline questionnaire; respondents
rated their level of agreement with the statement ‘I
don’t even bother to try and stay healthy’. Those
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the Don’t group, while those who disagreed strongly
or somewhat were assigned to the Doing group.
Lastly, those who responded with ‘Neither agree nor
disagree’ were assigned to the Should group. Differ-
ences in health knowledge, attitudes, and behaviours,
including diet, exercise and medication-taking behav-
iour, were assessed across the three groups.
Statistical analyses
Data from the SHIELD questionnaire were compared
with data derived from the 1999–2002 National
Health and Nutrition Examination Survey
(NHANES, n=10,780) for estimating the prevalence
of metabolic syndrome. NHANES includes self-
reported diagnosed conditions as well as clinical eval-
uation and laboratory testing to conﬁrm diagnoses
and to identify undiagnosed conditions (10,11). Indi-
viduals, ‡ 18 years old, were considered to have met-
abolic syndrome in NHANES if clinical criteria and
laboratory test results indicated at least three of the
following factors: waist circumference ‡ 102 cm
(40.2 inches) in men or ‡ 88 cm (34.6 inches) in
women, serum triglycerides ‡ 150 mg⁄dl, high-den-
sity lipoprotein cholesterol < 40 mg⁄dl in men or
<50mg⁄dl in women, blood pressure ‡130⁄85mmHg
or fasting serum glucose ‡ 110 mg⁄dl according to
the NCEP ATP III diagnostic criteria (2). Prevalence
estimates from SHIELD and NHANES were com-
puted stratiﬁed by age group and gender. Differences
among age groups and gender were tested using chi-
square test.
Comparisons across groups (type 1 and type 2 dia-
betes, high risk, low risk) for knowledge of metabolic
syndrome were made using ANOVA test. Compari-
sons across the ADA behaviour categories (‘Doing’,
‘Should’ and ‘Don’t’) for knowledge, attitudes and
behaviours were computed using ANOVA tests. Sta-
tistical signiﬁcance was set a priori as p < 0.01 as
multiple comparisons were made.
Results
Metabolic syndrome prevalence
In the SHIELD screening questionnaire, only 0.6% of
the total population (n=211,097) reported a meta-
bolic syndrome diagnosis. In contrast, NHANES
(n=10,780) data using clinical and laboratory crite-
ria indicated a metabolic syndrome prevalence of
25.9% in the adult population (Table 1). The
SHIELD respondents and NHANES participants were
similar to the US Census population, with 52% of all
three samples being aged 18–44 years; 51.8%
SHIELD, 50.8% NHANES, 51.9% US Census were
women; and 86.7% SHIELD, 71.7% NHANES, and
82.5% US Census were white. For household income,
39.1% SHIELD, 38.0% NHANES and 38.9% US
Census had incomes < $40,000 annually.
National Health and Nutrition Examination Sur-
vey results indicated that metabolic syndrome was
more prevalent among older respondents; 43% for
‡ 65 years of age vs. 16% for ages 18–44
(p < 0.0001). However, self-reporting of metabolic
syndrome did not vary widely across age groups in
SHIELD. Women were more likely than men to
report a metabolic syndrome diagnosis in SHIELD
and NHANES (p < 0.001) (Table 1).
Metabolic syndrome awareness
For SHIELD, there were 368 respondents with type 1
diabetes, 3849 with type 2 diabetes, 5389 at high risk
and 5673 at low risk. Type 2 diabetes and high-risk
respondents were more likely to be older, white or
male and to have lower incomes than respondents
with type 1 diabetes or low risk (p < 0.0001)
(Table 2).
Table 1 Prevalence estimates for metabolic syndrome from SHIELD and NHANES, by age and gender
Men Women Total
SHIELD
(n = 99,216)
NHANES
(n = 5395)
SHIELD
(n = 111,881)
NHANES
(n = 5385)
SHIELD
(n = 211,097)
NHANES
(n = 10,780)
Age 18–44 0.2 16.0 0.7 16.4 0.5 16.2
Age 45–64 0.4 33.7 1.1 33.7 0.8 33.7
Age 65+ 0.4 37.0 0.8 47.3 0.6 42.9**
All ages 0.3 24.4 0.9* 27.5* 0.6 25.9
*p < 0.001 for men vs. women for all ages. **p < 0.0001 for comparison across three age groups for total samples. SHIELD, Study
to Help Improve Early evaluation and management of risk factors Leading to Diabetes; NHANES, National Health and Nutrition
Examination Survey.
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observed between groups (type 1 and type 2 diabetes,
high risk and low risk) regarding awareness or
knowledge of metabolic syndrome (p > 0.05), but
awareness was consistently low across all groups
(Table 3). Across type 1 diabetes, type 2 diabetes,
high-risk and low-risk respondents, 13–14% indi-
cated they ‘have heard about’ metabolic syndrome,
and 9–11% reported that they ‘understand what’ the
syndrome is.
Knowledge, attitudes and behaviours
Because of the low rate of self-reported diagnosis of
metabolic syndrome and low awareness or under-
standing of the syndrome among SHIELD respon-
dents, the high-risk group (3–5 risk factors) was
used as a surrogate for metabolic syndrome risk. The
high-risk respondents have at least three of the ﬁve
hallmark risk factors identiﬁed by ATP III for meta-
bolic syndrome, including abdominal obesity, general
obesity as measured by BMI, dyslipidaemia and
hypertension. The high-risk group’s responses to
questionnaire items that related to health knowledge,
attitudes and behaviours were evaluated.
Knowledge
Metabolic syndrome and diabetes
Among the high-risk respondents, lack of knowledge
about metabolic syndrome was consistently high
Table 2 SHIELD respondent characteristics for baseline questionnaire
Characteristics
Type 2
diabetes
(n = 3849)
Type 1
diabetes
(n = 368)
High-risk
(3–5 risk
factors)
(n = 5389)
Low-risk
(0–2 risk
factors)
(n = 5673)
Age, years, n (%)*
18–44 489 (13) 232 (63) 951 (18) 2732 (48)
45–64 1905 (50) 128 (35) 2448 (45) 2023 (36)
‡ 65 1455 (38) 8 (2) 1990 (37) 918 (16)
Females, n (%)* 2219 (58) 227 (62) 3052 (57) 3713 (65)
Whites, n (%) 3268 (85) 333 (90) 4758 (88) 5008 (88)
Household income
< $40,000*
2020 (52) 155 (42) 2510 (47) 2067 (36)
Geographic region, n (%)
Northeast 758 (20) 64 (17) 1060 (20) 1068 (19)
South Atlantic 813 (21) 62 (17) 1080 (20) 1005 (18)
Central 1576 (41) 146 (40) 2264 (42) 2383 (42)
Mountain 217 (6) 40 (11) 313 (6) 407 (7)
Paciﬁc 485 (13) 56 (15) 672 (12) 810 (14)
*p < 0.001 for ANOVA across all four groups.
Table 3 Awareness of metabolic syndrome among SHIELD respondents from the baseline questionnaire
Proportion of
respondents agreeing
strongly or somewhat
Low risk: 0–2
risk factors
(n = 5673)
High risk:
3–5 risk factors
(n = 5389)
Type 1 diabetes
(n = 368)
Type 2 diabetes
(n = 3849)
Understand what
metabolic
syndrome is (%)
9.6 8.9 11.4 10.4
Have heard about
metabolic syndrome (%)
14.1 12.8 14.4 13.8
SHIELD, Study to Help Improve Early evaluation and management of risk factors Leading to Diabetes. Chi-square test, p > 0.05.
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‘Should’ and ‘Doing’). Less than 6% of the high-risk
respondents strongly agreed that they had heard
about metabolic syndrome and⁄or understood what
it was (Table 4). However, signiﬁcantly fewer of the
‘Should’ group compared with the ‘Doing’ and
‘Don’t’ groups knew about or understood metabolic
syndrome (p < 0.0001). There were signiﬁcant differ-
ences among the groups regarding diabetes knowl-
edge, with the ‘Don’t’ respondents being the least
informed (i.e. more likely to agree that diabetes is
only a sugar disease and⁄or that type 2 diabetes is
not as serious as type 1) (p < 0.001).
Obesity and weight loss
The high-risk attitude⁄behaviour groups had signiﬁ-
cantly different perceptions regarding the impact of a
hormone or metabolism problem on weight loss
(Table 4). ‘Doing’ and ‘Should’ respondents were less
likely to agree strongly that the inability to keep
weight off is due to a hormone or metabolism prob-
lem (5.2%) and (3.7%) than were ‘Don’t’ (11.4%)
respondents (p < 0.0001). More than half of the
‘Doing’ (56.0%) and ‘Don’t’ (51.9%) respondents
agreed strongly that obesity could aggravate or con-
tribute to the onset of chronic disease, compared
with 39.0% of the ‘Should’ respondents
(p < 0.0001).
Attitudes
Health status
The ‘Don’t’ group indicated poorer health status
than the ‘Doing’ and ‘Should’ groups (Table 4).
More ‘Don’t’ respondents (18.0%) agreed strongly
that they expected their health to get worse com-
pared with the ‘Should’ (5.9%) and ‘Doing’ (5.4%)
respondents (p < 0.0001). In response to the ques-
tionnaire item ‘I seem to get sick a little easier than
other people’, 4.5% of the ‘Doing’ respondents
agreed strongly compared with 4.8% and 10.1% of
the ‘Should’ and ‘Don’t’ groups respectively
(p < 0.0001). More than one-quarter of the respon-
dents in all groups were concerned that their health
problems would get worse over time, with more
‘Don’t’ respondents being very concerned (35.8%)
(p = 0.002).
Rating of current health
‘Don’t’ respondents were more likely to rate their
health as fair to poor (53.5%), compared with
‘Should’ (38%) or ‘Doing’ (26.8%) respondents
(p < 0.0001) (Table 4). When asked about their
health in comparison to 12 months ago, about half
of all respondents rated their current health as the
same. However, fewer ‘Doing’ respondents rated
their health as much or somewhat worse than
12 months ago (21.0%) compared with 25.2% of
‘Should’ and 32.8% of ‘Don’t’ respondents
(p < 0.0001).
Behaviours
Medication-taking behaviour
A majority of respondents reported a willingness to
take medications to prevent chronic disease; how-
ever, signiﬁcantly more ‘Doing’ (56.4%) than
‘Should’ (39.1%) or ‘Don’t’ (47.1%) respondents
agreed strongly that they were willing to take medi-
cations (p < 0.0001) (Table 4). However, the ‘Doing’
respondents reported the least preference for medica-
tion compared with lifestyle changes (2.3%), and
‘Don’t’ respondents reported the highest preference
for medication (12.8%) (p < 0.0001). The ‘Doing’
respondents were least likely to vary taking their pre-
scription medications depending on how they felt
(‘Doing’, 10.8%; ‘Should’, 16.6%; ‘Don’t’, 29.9%)
(p < 0.0001). In addition, more ‘Doing’ respondents
reported never rationing their medications (‘Doing’,
78.4%; ‘Should’, 70.1% and ‘Don’t’, 67.1%)
(p < 0.0001). Most respondents (> 86%) indicated
they had not stopped taking their medications in the
last 12 months against their doctor’s instruction or
approval, and the majority of all respondents
(> 84%) said they reﬁlled medication prescriptions
on time.
Diet, exercise and weight loss
Signiﬁcant differences were observed when respon-
dents were asked whether a healthcare provider had
recommended a change in diet or an increase in the
amount of exercise during the prior 12 months
(Table 4). More respondents were advised to increase
the amount they exercised than were advised to
change their diets, with more ‘Should’ respondents
receiving this exercise recommendation than ‘Doing’
or ‘Don’t’ respondents (‘Doing’, 51.1%; ‘Should’,
62.0% and ‘Don’t’, 56.8%) (p < 0.0001). Fewer
‘Doing’ respondents (43.1%) than ‘Should’ (51.8%)
and ‘Don’t’ (49.0%) respondents reported receiving a
recommendation from their healthcare provider to
change their diet (p < 0.0001). Signiﬁcantly more
‘Doing’ (78.6%) respondents than ‘Should’ (58.6%)
and ‘Don’t’ (48.5%) respondents reported exercising
some or regularly (p < 0.0001).
Among respondents in all groups who indicated
an inability to maintain their target weight over the
past 6 months, a similar percentage across groups
(51–55%) disagreed that a hormone or metabolism
problem was responsible for their own inability to
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Topic (%)
Already Doing It
(Doing) n = 2896
(%)
I Know I Should
(Should) n = 2149
(%)
Don’t Bother
Me (Don’t)
n = 341 (%)
Knowledge
1. I have heard about metabolic syndrome or syndrome X
1* 5.5 3.5 5.9
2. I understand what metabolic syndrome or syndrome X is
1* 5.1 2.8 5.1
3. Diabetes is only a sugar disease
1* 3.8 2.3 12.0
4. Type 2 diabetes is not as serious as type 1 diabetes
1* 3.4 2.3 8.3
5. The inability to keep weight off is due to
a hormone or metabolism problem
1*
5.2 3.7 11.4
6. Obesity could aggravate or contribute to the
onset of chronic diseases
1*
56.0 39.0 51.9
Attitude
7. I expect my health to get worse
1* 5.4 5.9 18.0
8. I seem to get sick a little easier than other people
1* 4.5 4.8 10.1
9. How concerned are you that your health
problems will get worse over time?
2*
27.0 26.3 35.8
10. Would you say your health is excellent,
very good, good, fair or poor?
3*
26.8 38.0 53.5
11. Compared with 12 months ago, how would you
rate your health today?
4*
21.0 25.2 32.8
Behaviour
Medication taking
12. Willing to take medication to prevent chronic disease
1* 56.4 39.1 47.1
13. Prefer taking medications rather than change my lifestyle
1* 2.3 3.6 12.8
14. Vary how take prescription medications depending on how I feel
5* 10.8 16.6 29.9
15. How often reﬁll prescription medications on time?
6* 92.7 89.8 84.3
16. How often ration medications (skip dose to help prescription last longer)?
7* 21.6 29.9 32.9
17. Stopped taking medications against doctors’ instructions
during the past 12 months
8*
90.4 87.2 86.9
Exercise
18. Healthcare provider recommended an increase
in amount of exercise in past 12 months
8*
48.9 38.0 43.2
19. Current exercise routine, exercise some or regularly* 78.6 58.6 48.5
Diet
20. Healthcare provider recommended change
in diet in the last 12 months
8*
56.9 48.2 51.0
21. During the last 12 months, have you tried to lose weight?
8* 25.8 30.4 35.8
22. Have you maintained your desired weight for more than 6 months?
8* 67.5 75.0 75.1
23. If no, do you believe that it is due to what
you eat and how much you exercise?
8
13.0 11.6 12.5
24. If no, do you believe it is due to an undiagnosed
hormone or metabolism problem?*
55.1 55.2 51.3
25. How often do you follow an eating plan prescribed
by a physician, nutritionist or dietician?
9*
17.9 8.2 9.5
26. How often do you try to make healthy choices about what you eat?
9* 83.1 56.3 48.4
27. How often do you eat breakfast?
9* 75.0 62.8 59.1
Alcohol and tobacco behaviour
28. Alcohol consumption, ‡ 5 drinks per day in past 4 weeks 7.0 6.7 10.9
29. Smoking history, never smoked* 45.7 45.7 44.3
*p < 0.01 for ANOVA comparison across all three groups. n varies slightly per question.
1 = agree strongly; 2 = very concerned; 3 = fair or poor; 4 = somewhat or much worse; 5 = agree strongly or somewhat; 6 = almost always or always;
7 = a little to all of the time; 8 = no and 9 = most of the time to always.
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ferences among the groups regarding their perception
of the impact of diet and exercise habits on their
inability to maintain their target weight; only 12–
13% disagreed that not maintaining desired weight
was due to eating and exercise habits.
The majority of respondents (> 60%) in all three
groups tried to lose weight in the previous
12 months, but fewer ‘Doing’ respondents than
‘Should’ or ‘Don’t’ respondents reported not trying
to lose weight [‘Doing’, 25.8%; ‘Should’, 30.4% and
‘Don’t’, 35.8% (p < 0.0001)] (Table 4). The majority
(> 82%) of respondents in all groups were not cur-
rently following a prescribed eating plan, although
83.1% of the ‘Doing’ group reported making healthy
choices about eating most or all of the time, com-
pared with 56.3% of the ‘Should’ and 48.4% of the
‘Don’t’ respondents (p < 0.0001). Three-quarters
(75%) of the ‘Doing’ group reported eating breakfast
all or most of the time, compared with approxi-
mately 60% of the ‘Should’ and ‘Don’t’ respondents
(p < 0.0001).
Alcohol and tobacco use
There were no signiﬁcant differences among groups
regarding alcohol consumption (Table 4). There
were, however, signiﬁcant differences in smoking
habits, with fewer ‘Doing’ respondents (12.9%)
reporting that they currently smoke, compared with
‘Should’ (19.2%) and ‘Don’t’ (22.4%) respondents
(p < 0.01). In addition, 45.7% of ‘Doing’ and
‘Should’ respondents reported never smoking, com-
pared with 44.3% of ‘Don’t’ respondents.
Discussion
Study to Help Improve Early evaluation and man-
agement of risk factors Leading to Diabetes pro-
vides unique insight into US adults’ awareness of
metabolic syndrome. In the screening questionnaire,
very few respondents (0.6%) self-reported having
metabolic syndrome, compared with 25.9% in
NHANES. In the baseline questionnaire, an evalua-
tion of the high-risk respondent group who has
several components of metabolic syndrome demon-
strated that respondents’ knowledge, attitudes and
behaviours toward health, exercise and diet varied
considerably. When this group of respondents was
classiﬁed according to their response to the ques-
tionnaire item ‘I don’t even bother to try and stay
healthy’, clear distinctions could be seen between
those who reported taking an active approach to
improve their health (‘Doing’ respondents) and
those who did not (‘Should’ and ‘Don’t’
respondents).
Knowledge was inconsistent within and among the
three high-risk attitude⁄behaviour groups, with
respondents generally lacking knowledge about or
awareness of metabolic syndrome. Many respondents
also did not demonstrate knowledge about diabetes,
although most were aware of the impact of obesity
on chronic conditions in general.
Respondents’ attitudes toward health were more
favourable in those already committed to healthy
behaviours (Doing), with poorer health attitudes
observed in those who knew they should take better
care of themselves (Should) and those who knew it
was important, but did not bother (Don’t). The most
interesting ﬁndings, and perhaps most useful for
clinical practice, were the observed associations
between these general attitude groups and associated
behaviour patterns. Regarding medication-taking
behaviour, all respondents were willing to take medi-
cations to prevent chronic disease, but the ‘Don’t’
group was the most likely to prefer medication to
lifestyle changes. Complicating this as a treatment
option, however, was the observation that this group
was also the most likely to report changing their
medication-taking patterns and rationing their medi-
cations. Members of the ‘Don’t’ group would be
more difﬁcult to treat because of diet, exercise and
medication-taking habits. It is likely that individuals
with these characteristics would require substantial
support to change their health-related attitudes and
behaviours, and they may never embrace such
changes. On the other hand, the ‘Doing’ respondents
reported adherent medication-taking behaviour and
consistently healthy diet and exercise habits. Lastly,
respondents in the ‘Should’ group reported a willing-
ness to take medications, but seemed more ambiva-
lent regarding medication-taking vs. lifestyle changes,
and reported poorer medication-taking behaviour
than the ‘Doing’ group. With appropriate support,
the ‘Should’ group may represent the greatest oppor-
tunity for successful intervention.
Fifty per cent or more of the ‘Should’ and ‘Don’t’
respondents reported being told by their healthcare
provider to exercise more and⁄or change their diet.
Whereas most said they had tried to lose weight,
their reported diet and exercise patterns were incon-
sistent with doing so. The ‘Doing’ respondents also
received recommendations for diet and exercise
improvements, but reported behaviours were more
consistent with those recommendations.
These ﬁndings from SHIELD on knowledge, atti-
tudes and behaviours are unique. There is currently
little to no information in the literature that has evalu-
ated patients’ health-related behaviour in the context
of knowledge and attitudes around metabolic syn-
drome. However, the connection between knowledge
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in diabetes (12–14). Therefore, identifying another
model that can distinguish patients likely to adopt
treatment recommendations from those who are not
is important; such a model may help to identify the
most appropriate treatment options for patients with
different attitudes and knowledge levels. The SHIELD
data suggest that respondents who report trying to be
healthy are most likely to embrace lifestyle changes
and exhibit good medication-taking behaviour, and
are less likely to smoke. Respondents who know that
treatment and behaviours are important, but do not
care, may be the most difﬁcult to treat as they prefer
medication over lifestyle changes and are also least
likely to take medications appropriately and more
likely to smoke. The group in the middle, those who
know treatment and behaviours are important but
who are not yet taking needed action, may constitute
the greatest opportunity for behavioural intervention.
This study provides evidence of the health atti-
tudes and behaviours in a large US population sam-
ple of respondents at high risk for metabolic
syndrome with a high questionnaire response rate.
However, there are limitations to the study that
should be considered. Only a small percentage (5–
8%) of consumers invited to participate in the TNS
panel elect to do so and those who participate are
accustomed to completing questionnaires, leading to
possible selection bias. Household panels tend to
under-represent the very wealthy and very poor seg-
ments of the population, and do not include military
or institutionalised individuals, which is true for
most random sampling and clinically based method-
ologies. Additionally, the determination of metabolic
syndrome and high risk in SHIELD was made based
upon self-report rather than clinical or laboratory
measures, possibly contributing to the low prevalence
of metabolic syndrome reported in SHIELD.
Conclusions
The lack of knowledge about metabolic syndrome
reported in SHIELD suggests that this concept has
achieved limited penetration into the public aware-
ness. Given that the actual prevalence of metabolic
syndrome is considerably higher than that observed
by self-report, increased awareness of the cluster of
risk factors deﬁned as metabolic syndrome and edu-
cation regarding their association with diabetes and
CVD risk have the potential to beneﬁt a substantial
portion of the US adult population if such awareness
can lead to behaviour changes. SHIELD has also pro-
vided a unique opportunity to further understand
the characteristics of individuals who may be most
likely to beneﬁt from health-improving interventions,
while also identifying the characteristics of those who
have already succeeded, as well as those who may be
most difﬁcult to reach.
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